ATRX and neoplasm: CODEX's normalization and segmentation accuracy is further evaluated through the analysis of the WES data of 222 neuroblastoma matched tumor/blood samples from the TARGET project (20), with a focus on the well-studied ATRX gene region (20,33,34).